loadpatents
Patent applications and USPTO patent grants for Boivin; Roch.The latest application filed is for "pyrimidinone derivatives as shp2 antagonists".
Patent | Date |
---|---|
Tetrahydropyrazolopyrimidine compounds Grant 11,130,758 - Boivin , et al. September 28, 2 | 2021-09-28 |
Pyrimidinone Derivatives As Shp2 Antagonists App 20210179565 - JORAND-LEBRUN; Catherine ;   et al. | 2021-06-17 |
Carboxamide-pyrimidine derivatives as SHP2 antagonists Grant 11,033,547 - Jorand-LeBrun , et al. June 15, 2 | 2021-06-15 |
Pyrimidinone derivatives as SHP2 antagonists Grant 11,001,561 - Jorand-Lebrun , et al. May 11, 2 | 2021-05-11 |
Quinoline Compounds As Irak Inhibitors And Uses Thereof App 20200369646 - JORAND-LEBRUN; Catherine ;   et al. | 2020-11-26 |
Tetrahydropyrazolopyrimidine Compounds App 20200347050 - BOIVIN; Roch ;   et al. | 2020-11-05 |
Pyrimidinone Derivatives As Shp2 Antagonists App 20200317622 - Jorand-Lebrun; Catherine ;   et al. | 2020-10-08 |
Carboxamide-pyrimidine Derivatives As Shp2 Antagonists App 20200281926 - JORAND-LEBRUN; Catherine ;   et al. | 2020-09-10 |
Tetrahydropyrazolopyrimidine compounds Grant 10,640,500 - Boivin , et al. | 2020-05-05 |
Substituted pyrido[3,4-d]pyrimidines and pyrido[4,3-d]pyrimidines as p70S6K inhibitors Grant 10,233,160 - Huck , et al. | 2019-03-19 |
Tetrahydropyrazolopyrimidine Compounds App 20180273532 - Boivin; Roch ;   et al. | 2018-09-27 |
Azaquinazoline Carboxamide Derivatives App 20180237402 - HUCK; Bayard R. ;   et al. | 2018-08-23 |
Substituted benzo[d][1,2,3]triazines as p70S6K inhibitors Grant 9,981,925 - Huck , et al. May 29, 2 | 2018-05-29 |
Tetrahydropyrazolopyrimidine compounds Grant 9,850,242 - Boivin , et al. December 26, 2 | 2017-12-26 |
Selectively substituted quinoline compounds Grant 9,663,486 - Boivin , et al. May 30, 2 | 2017-05-30 |
Tetrahydropyrazolopyrimidine Compounds App 20160339032 - Boivin; Roch ;   et al. | 2016-11-24 |
Azaquinazoline Carboxamide Derivatives App 20160340323 - HUCK; Bayard R. ;   et al. | 2016-11-24 |
Tetrahydropyrazolopyrimidine compounds Grant 9,446,046 - Boivin , et al. September 20, 2 | 2016-09-20 |
Substituted pyrido[3,2-d]pyrimidines for treating cancer Grant 9,440,968 - Huck , et al. September 13, 2 | 2016-09-13 |
Selectively Substituted Quinoline Compounds App 20160176841 - BOIVIN; Roch ;   et al. | 2016-06-23 |
Tetrahydropyrazolopyrimidine Compounds App 20160030430 - Boivin; Roch ;   et al. | 2016-02-04 |
Azaquinazoline Carboxamide Derivatives App 20150259339 - Huck; Bayard R. ;   et al. | 2015-09-17 |
Tetrahydropyrazolopyrimidine compounds Grant 9,126,999 - Boivin , et al. September 8, 2 | 2015-09-08 |
Tetrahydropyrazolopyrimidine Compounds App 20130324547 - Boivin; Roch ;   et al. | 2013-12-05 |
Intermediates And Methods For Making Zearalenone Macrolide Analogs App 20130211103 - Boivin; Roch ;   et al. | 2013-08-15 |
Macrocyclic Compounds Useful As Pharmaceuticals App 20130196987 - Boivin; Roch ;   et al. | 2013-08-01 |
Intermediates and methods for making zearalenone macrolide analogs Grant 8,350,059 - Boivin , et al. January 8, 2 | 2013-01-08 |
Macrocyclic compounds useful as pharmaceuticals Grant 8,329,742 - Boivin , et al. December 11, 2 | 2012-12-11 |
Intermediates And Methods For Making Zearalenone Macrolide Analogs App 20110237805 - Boivin; Roch ;   et al. | 2011-09-29 |
Macrocyclic Compounds Useful As Pharmaceuticals App 20110144101 - Boivin; Roch ;   et al. | 2011-06-16 |
Macrocyclic compounds useful as pharmaceuticals Grant 7,799,827 - Boivin , et al. September 21, 2 | 2010-09-21 |
Enantiomerically Enriched Imidazoazepinone Compounds App 20090197867 - Spyvee; Mark ;   et al. | 2009-08-06 |
Macrocyclic compounds useful as pharmaceuticals App 20060247448 - Boivin; Roch ;   et al. | 2006-11-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.